Mobile Sensing and Support for Depression

NCT ID: NCT02776839

Last Updated: 2017-06-02

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 126 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-03-31
• Study Completion Date: 2015-12-31

Brief Summary

The objective of this study is two fold, first to explore the potential of context sensitive intervention delivery to provide in-situ support for people with depressive symptoms, second to explore the detection of daily-life behavior based on smart phone sensor information to identify subjects with a clinically meaningful depression level.

Detailed Description

To conduct a very first pilot trial, a monocentric, single-arm clinical study is conducted. The study is approved by the local ethics committee of the Canton of Zurich in Switzerland and the Swiss Agency for Therapeutic Products. It is conducted in full accordance with the Declaration of Helsinki, with all subjects providing their electronic informed consent prior to participation. As the main interest lies in a proof of concept of the proposed MOSS app, emphasis is put on real life conditions. A range of different recruitment channels is used to attract subjects from the general public; they include physical flyers, online posts on relevant online bulletin boards and the Google Play Store.

Conditions

Depression

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Study Groups

Mobile Sensing

This phase of the study is designed to develop the app. due to algorithms the app should lern to detect depressive symptoms

Group Type: OTHER

Mobile sensing

Intervention Type: DEVICE

Interventions

Mobile sensing

Intervention Type: DEVICE

Other Intervention Names

Mobile app

Eligibility Criteria

Inclusion Criteria

• self-declaration of depressive symptoms
• app runs on Android 4.0 and higher
• germen speaking

Exclusion Criteria

• psychotic symptoms
• bipolar symptoms
• drug or alcohol dependency
• dementia

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Switzerland: ETH

UNKNOWN

Sponsor Role: collaborator

Switzerland: Makora

UNKNOWN

Sponsor Role: collaborator

University of Zurich

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

S Weidt, MD

Role: PRINCIPAL_INVESTIGATOR

University of Zurich

Other Identifiers

MOSS

Identifier Type: -

Identifier Source: org_study_id